Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
JP
Josh Peters
CEO
Prox Biosciences
Work experience
Prox Biosciences
CEO
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Expertise
Immunotherapy
Machine Learning
Translational Science
Last updated Feb 2024
Report Error
Publications
13
Funding
0
Patents
0
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
Immunity 55 (5), 827-846. e10, 2022
Computational methods for single-cell RNA sequencing
Annual Review of Biomedical Data Science 3, 339-364, 2020
Artificial neural networks enable genome-scale simulations of intracellular signaling
Nature Communications 13 (1), 3069, 2022
JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia
Med 3 (1), 42-57. e5, 2022
Multimodal profiling of lung granulomas reveals cellular correlates of tuberculosis control
bioRxiv, 2020.10. 24.352492, 2020
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Cell 186 (25), 5536-5553. e22, 2023
Consensus transcriptional states describe human mononuclear phagocyte diversity in the lung across health and disease
bioRxiv, 2020.08. 06.240424, 2020
Protective intravenous BCG vaccination induces enhanced immune signaling in the airways
bioRxiv, 2023.07. 16.549208, 2023
Fc-engineered antibodies leverage neutrophils to drive control of Mycobacterium tuberculosis
bioRxiv, 2022.05. 01.490220, 2022
Uncovering complex molecular networks in host–pathogen interactions using systems biology
Emerging Topics in Life Sciences, 2019
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs
Nature Communications 15 (1), 1900, 2024
TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo
Msystems 8 (4), e00052-23, 2023
Compressed phenotypic screens for complex multicellular models and high-content assays
bioRxiv, 2023
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.
Create account
Already have an account?
Sign in
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact us
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.